-
Je něco špatně v tomto záznamu ?
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Y. Handelsman, JE. Anderson, GL. Bakris, CM. Ballantyne, JA. Beckman, DL. Bhatt, ZT. Bloomgarden, B. Bozkurt, MJ. Budoff, J. Butler, S. Dagogo-Jack, IH. de Boer, RA. DeFronzo, RH. Eckel, D. Einhorn, VA. Fonseca, JB. Green, G. Grunberger, C....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
NLK
ProQuest Central
od 2003-01-01 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest)
od 2003-01-01 do Před 2 měsíci
Health & Medicine (ProQuest)
od 2003-01-01 do Před 2 měsíci
Family Health Database (ProQuest)
od 2003-01-01 do Před 2 měsíci
- MeSH
- chronická renální insuficience * komplikace epidemiologie terapie MeSH
- diabetes mellitus 2. typu * komplikace epidemiologie terapie MeSH
- hypoglykemika terapeutické užití MeSH
- kardiovaskulární nemoci * komplikace epidemiologie prevence a kontrola MeSH
- kardiovaskulární systém * MeSH
- lidé MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular disease (ASCVD), and heart failure (HF)-along with their associated risk factors-have overlapping etiologies, and two or more of these conditions frequently occur in the same patient. Many recent cardiovascular outcome trials (CVOTs) have demonstrated the benefits of agents originally developed to control T2D, ASCVD, or CKD risk factors, and these agents have transcended their primary indications to confer benefits across a range of conditions. This evolution in CVOT evidence calls for practice recommendations that are not constrained by a single discipline to help clinicians manage patients with complex conditions involving diabetes, cardiorenal, and/or metabolic (DCRM) diseases. The ultimate goal for these recommendations is to be comprehensive yet succinct and easy to follow by the nonexpert-whether a specialist or a primary care clinician. To meet this need, we formed a volunteer task force comprising leading cardiologists, nephrologists, endocrinologists, and primary care physicians to develop the DCRM Practice Recommendations, a multispecialty consensus on the comprehensive management of the patient with complicated metabolic disease. The task force recommendations are based on strong evidence and incorporate practical guidance that is clinically relevant and simple to implement, with the aim of improving outcomes in patients with DCRM. The recommendations are presented as 18 separate graphics covering lifestyle therapy, patient self-management education, technology for DCRM management, prediabetes, cognitive dysfunction, vaccinations, clinical tests, lipids, hypertension, anticoagulation and antiplatelet therapy, antihyperglycemic therapy, hypoglycemia, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), ASCVD, HF, CKD, and comorbid HF and CKD, as well as a graphical summary of medications used for DCRM.
Baylor College of Medicine Houston TX USA
Brigham and Women's Hospital Harvard Medical School Boston MA USA
David Geffen School of Medicine UCLA Los Angeles CA USA
Duke University Medical Center Durham NC USA
Emory University Atlanta GA USA
Johns Hopkins University School of Medicine Baltimore MD USA
Metabolic Institute of America Tarzana CA USA
Mount Sinai School of Medicine New York NY USA
Saint Luke's Mid America Heart Institute University of Missouri Kansas City Kansas City MO USA
Scripps Whittier Institute for Diabetes San Diego CA USA
The Frist Clinic Nashville TN USA
Tulane University Health Sciences Center New Orleans LA USA
University of California at Irvine Irvine CA USA
University of California San Diego School of Medicine San Diego CA USA
University of Chicago Medicine Chicago IL USA
University of Colorado Anschutz Medical Campus Denver CO USA
University of Maryland School of Medicine Baltimore MD USA
University of Mississippi Medical Center Jackson MS USA
University of Tennessee Health Science Center Memphis TN USA
University of Texas Health Science Center San Antonio TX USA
University of Washington Seattle WA USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011166
- 003
- CZ-PrNML
- 005
- 20220506130019.0
- 007
- ta
- 008
- 220425s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jdiacomp.2021.108101 $2 doi
- 035 __
- $a (PubMed)34922811
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Handelsman, Yehuda $u Metabolic Institute of America, Tarzana, CA, USA. Electronic address: yhandelsman@gmail.com
- 245 10
- $a DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases / $c Y. Handelsman, JE. Anderson, GL. Bakris, CM. Ballantyne, JA. Beckman, DL. Bhatt, ZT. Bloomgarden, B. Bozkurt, MJ. Budoff, J. Butler, S. Dagogo-Jack, IH. de Boer, RA. DeFronzo, RH. Eckel, D. Einhorn, VA. Fonseca, JB. Green, G. Grunberger, C. Guerin, SE. Inzucchi, PS. Jellinger, MN. Kosiborod, P. Kushner, N. Lepor, CW. Mende, ED. Michos, J. Plutzky, PR. Taub, GE. Umpierrez, M. Vaduganathan, MR. Weir
- 520 9_
- $a Type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular disease (ASCVD), and heart failure (HF)-along with their associated risk factors-have overlapping etiologies, and two or more of these conditions frequently occur in the same patient. Many recent cardiovascular outcome trials (CVOTs) have demonstrated the benefits of agents originally developed to control T2D, ASCVD, or CKD risk factors, and these agents have transcended their primary indications to confer benefits across a range of conditions. This evolution in CVOT evidence calls for practice recommendations that are not constrained by a single discipline to help clinicians manage patients with complex conditions involving diabetes, cardiorenal, and/or metabolic (DCRM) diseases. The ultimate goal for these recommendations is to be comprehensive yet succinct and easy to follow by the nonexpert-whether a specialist or a primary care clinician. To meet this need, we formed a volunteer task force comprising leading cardiologists, nephrologists, endocrinologists, and primary care physicians to develop the DCRM Practice Recommendations, a multispecialty consensus on the comprehensive management of the patient with complicated metabolic disease. The task force recommendations are based on strong evidence and incorporate practical guidance that is clinically relevant and simple to implement, with the aim of improving outcomes in patients with DCRM. The recommendations are presented as 18 separate graphics covering lifestyle therapy, patient self-management education, technology for DCRM management, prediabetes, cognitive dysfunction, vaccinations, clinical tests, lipids, hypertension, anticoagulation and antiplatelet therapy, antihyperglycemic therapy, hypoglycemia, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), ASCVD, HF, CKD, and comorbid HF and CKD, as well as a graphical summary of medications used for DCRM.
- 650 12
- $a kardiovaskulární nemoci $x komplikace $x epidemiologie $x prevence a kontrola $7 D002318
- 650 12
- $a kardiovaskulární systém $7 D002319
- 650 12
- $a diabetes mellitus 2. typu $x komplikace $x epidemiologie $x terapie $7 D003924
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypoglykemika $x terapeutické užití $7 D007004
- 650 12
- $a chronická renální insuficience $x komplikace $x epidemiologie $x terapie $7 D051436
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Anderson, John E $u The Frist Clinic, Nashville, TN, USA
- 700 1_
- $a Bakris, George L $u University of Chicago Medicine, Chicago, IL, USA
- 700 1_
- $a Ballantyne, Christie M $u Baylor College of Medicine, Houston, TX, USA
- 700 1_
- $a Beckman, Joshua A $u Vanderbilt University Medical Center, Nashville, TN, USA
- 700 1_
- $a Bhatt, Deepak L $u Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- 700 1_
- $a Bloomgarden, Zachary T $u Mount Sinai School of Medicine, New York, NY, USA
- 700 1_
- $a Bozkurt, Biykem $u Baylor College of Medicine, Houston, TX, USA
- 700 1_
- $a Budoff, Matthew J $u David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
- 700 1_
- $a Butler, Javed $u University of Mississippi Medical Center, Jackson, MS, USA
- 700 1_
- $a Dagogo-Jack, Samuel $u University of Tennessee Health Science Center, Memphis, TN, USA
- 700 1_
- $a de Boer, Ian H $u University of Washington, Seattle, WA, USA
- 700 1_
- $a DeFronzo, Ralph A $u University of Texas Health Science Center, San Antonio, TX, USA
- 700 1_
- $a Eckel, Robert H $u University of Colorado Anschutz Medical Campus, Denver, CO, USA
- 700 1_
- $a Einhorn, Daniel $u Scripps Whittier Institute for Diabetes, San Diego, CA, USA
- 700 1_
- $a Fonseca, Vivian A $u Tulane University Health Sciences Center, New Orleans, LA, USA
- 700 1_
- $a Green, Jennifer B $u Duke University Medical Center, Durham, NC, USA
- 700 1_
- $a Grunberger, George $u Grunberger Diabetes Institute, Bloomfield Hills, MI, USA, Wayne State University School of Medicine, Detroit, MI, USA, Oakland University William Beaumont School of Medicine, Rochester, MI, USA, Charles University, Prague, Czech Republic
- 700 1_
- $a Guerin, Chris $u University of California San Diego School of Medicine, San Diego, CA, USA
- 700 1_
- $a Inzucchi, Silvio E $u Yale School of Medicine, New Haven, CT, USA
- 700 1_
- $a Jellinger, Paul S $u The Center for Diabetes & Endocrine Care, University of Miami Miller School of Medicine, Hollywood, FL, USA
- 700 1_
- $a Kosiborod, Mikhail N $u Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO, USA
- 700 1_
- $a Kushner, Pamela $u University of California at Irvine, Irvine, CA, USA
- 700 1_
- $a Lepor, Norman $u David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
- 700 1_
- $a Mende, Christian W $u University of California San Diego School of Medicine, San Diego, CA, USA
- 700 1_
- $a Michos, Erin D $u Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 700 1_
- $a Plutzky, Jorge $u Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- 700 1_
- $a Taub, Pam R $u University of California San Diego School of Medicine, San Diego, CA, USA
- 700 1_
- $a Umpierrez, Guillermo E $u Emory University, Atlanta, GA, USA
- 700 1_
- $a Vaduganathan, Muthiah $u Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- 700 1_
- $a Weir, Matthew R $u University of Maryland School of Medicine, Baltimore, MD, USA
- 773 0_
- $w MED00002638 $t Journal of diabetes and its complications $x 1873-460X $g Roč. 36, č. 2 (2022), s. 108101
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34922811 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130011 $b ABA008
- 999 __
- $a ok $b bmc $g 1788988 $s 1162364
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 36 $c 2 $d 108101 $e 20211207 $i 1873-460X $m Journal of diabetes and its complications $n J. Diabetes Complicat. $x MED00002638
- LZP __
- $a Pubmed-20220425
